HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nam Yoon Kim Selected Research

Sulindac (Copal)

7/2014CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nam Yoon Kim Research Topics

Disease

2Neoplasms (Cancer)
07/2014 - 11/2012
2Kaposi Sarcoma (Kaposi's Sarcoma)
11/2012 - 01/2012
1Adenoma (Adenomas)
07/2014
1Colonic Neoplasms (Colon Cancer)
07/2014
1Intestinal Polyposis (Polyposis, Intestinal)
07/2014
1Carcinogenesis
11/2012

Drug/Important Bio-Agent (IBA)

1InterleukinsIBA
07/2014
1Sulindac (Copal)FDA LinkGeneric
07/2014
1Interleukin-8 (Interleukin 8)IBA
07/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012
1Biological ProductsIBA
11/2012
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2012
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
01/2012